Impact of natalizumab on cognitive performances and fatigue in relapsing multiple sclerosis: a prospective, open-label, two years observational study.
<h4>Background and objectives</h4>Natalizumab reduces the relapse rate and magnetic resonance imaging activity in patients with Relapsing-Remitting Multiple Sclerosis (RRMS). So far the influence of natalizumab on cognitive functions and fatigue in MS remains uncertain. The aim of this p...
Main Authors: | Pietro Iaffaldano, Rosa Gemma Viterbo, Damiano Paolicelli, Guglielmo Lucchese, Emilio Portaccio, Benedetta Goretti, Vita Direnzo, Mariangela D'Onghia, Stefano Zoccolella, Maria Pia Amato, Maria Trojano |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22558238/?tool=EBI |
Similar Items
-
Low serum urate levels are associated to female gender in multiple sclerosis patients.
by: Stefano Zoccolella, et al.
Published: (2012-01-01) -
Review of interferon beta-1b in the treatment of early and relapsing multiple sclerosis
by: Damiano Paolicelli, et al.
Published: (2009-07-01) -
The Cost of Relapsing-Remitting Multiple Sclerosis Patients Who Develop Neutralizing Antibodies during Interferon Beta Therapy.
by: Damiano Paolicelli, et al.
Published: (2016-01-01) -
Lymphocyte Count and Body Mass Index as Biomarkers of Early Treatment Response in a Multiple Sclerosis Dimethyl Fumarate-Treated Cohort
by: Alessia Manni, et al.
Published: (2019-06-01) -
Aferesi terapeutica nelle malattie del Sistema Nervoso Centrale
by: Carlo Tortorella, et al.
Published: (2013-07-01)